iQure Pharma Inc.

is a biotechnology and pharmaceutical startup based in the United States, founded in 2019. The company's slogan "Providing attractive therapies to patients and physicians while ensuring significant return on investment for investors" encapsulates its mission. iQure Pharma is focused on developing new therapeutic solutions by leveraging academic research and industry expertise. The company's core competencies include scouting for innovative compounds from academic research, evaluating out-licensing opportunities with big pharma and biotech, and selecting compounds with significant attractive target profiles for commercialization. Additionally, iQure Pharma is dedicated to driving preclinical and clinical development activities while ensuring regulatory and quality compliance. In October 11, 2023, iQure Pharma secured a $1.20M Venture Round investment from Ventura BioMed Investors and OKG Capital. This investment signifies the confidence that these investors have in iQure Pharma's potential for delivering impactful therapies and generating attractive returns. With its unique positioning and focus on bridging academia and industry, iQure Pharma holds promise for both patients and investors seeking meaningful healthcare innovations and sustainable financial growth.